Briefing

Featured article

FDA approves GSK’s Ojjaara for treating myelofibrosis patients with anaemia

Also in this section

News in Numbers

Latest News

Latest Deals

Project Updates

Trends & Insight

02/24/2024 04:44:53
  • Home | How pharma wants to break the efficacy ceiling in IBD
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Ursatec
  • SHL Medical Company Insight
  • SHL Medical
  • Controlant
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Trends & Insight
  • Owen Mumford Company Insight
  • Owen Mumford
  • Sensified.io
  • In Depth
  • How pharma wants to break the efficacy ceiling in IBD
  • Subcutaneous drugs grant a new lease on life to checkpoint inhibitors
  • Hope for the UK clinical trial landscape but it requires a lot of work
  • Novo Nordisk’s Wegovy to start being supplied by NHS in England
  • Minimal impact expected for first ten drugs released for Medicare price negotiation
  • Q&A: Human touch remains critical for the patient experience in trials
  • Zenatek Company Insight
  • BEA Technologies
  • Listings
  • Events
  • Awards
  • Buyer's Guides
  • Next issue
10/02/2023 00:00:00